Therefore, PARN serves as a crucial regulator of β-cell secretory capacity, and targeting the PARN–PTBP1–mRNA axis may offer novel therapeutic avenues for improving insulin secretion in diabetes. The gene discussed is PTBP1; the disease is diabetes mellitus.